1HUL
A NOVEL DIMER CONFIGURATION REVEALED BY THE CRYSTAL STRUCTURE AT 2.4 ANGSTROMS RESOLUTION OF HUMAN INTERLEUKIN-5
1HUL の概要
| エントリーDOI | 10.2210/pdb1hul/pdb |
| 分子名称 | INTERLEUKIN-5 (2 entities in total) |
| 機能のキーワード | cytokine |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Secreted: P05113 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 24792.71 |
| 構造登録者 | |
| 主引用文献 | Milburn, M.V.,Hassell, A.M.,Lambert, M.H.,Jordan, S.R.,Proudfoot, A.E.,Graber, P.,Wells, T.N. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature, 363:172-176, 1993 Cited by PubMed Abstract: Interleukin-5 (IL-5) is a lineage-specific cytokine for eosinophilpoiesis and plays an important part in diseases associated with increased eosinophils, such as asthma. Human IL-5 is a disulphide-linked homodimer with 115 amino-acid residues in each chain. The crystal structure at 2.4 A resolution reveals a novel two-domain structure, with each domain showing a striking similarity to the cytokine fold found in granulocyte macrophage and macrophage colony-stimulating factors, IL-2 (ref. 5), IL-4 (ref. 6), and human and porcine growth hormones. IL-5 is unique in that each domain requires the participation of two chains. The IL-5 structure consists of two left-handed bundles of four helices laid end to end and two short beta-sheets on opposite sides of the molecule. Surprisingly, the C-terminal strand and helix of one chain complete a bundle of four helices and a beta-sheet with the N-terminal three helices and one strand of the other chain. The structure of IL-5 provides a molecular basis for the design of antagonists and agonists that would delineate receptor recognition determinants critical in signal transduction. This structure determination extends the family of the cytokine bundle of four helices and emphasizes its fundamental significance and versatility in recognizing its receptor. PubMed: 8483502DOI: 10.1038/363172a0 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.4 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






